 LOS ANGELES--BUSINESS WIRE--- IPHA classaction--The Law Offices of Frank R. Cruz announces an investigation of Innate Pharma SA Innate or the Company NASDAQ: IPHA on behalf of investors concerning the Companys possible violations of federal securities laws. If you are a shareholder who suffered a loss, click here to participate. On October 23, 2018, Innate and AstraZeneca plc AstraZeneca announced an expansion of a pre-existing collaboration agreement, whereby AstraZeneca acquired 9.8 equity stake 